ROSIER financials
ROSIER
549300WSAOH6EKIHN557 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | €233.8M | €202.6M |
| Other income | €1.2M | €1.2M |
| Operating expenses | €271.7M | €224.9M |
| Employee benefits expense | €17.4M | €17.8M |
| Raw materials & consumables used | €182.0M | €152.6M |
| Operating profit (EBIT) | -€36.7M | -€21.2M |
| Finance costs | €1.2M | €1.3M |
| Profit before tax | -€37.6M | -€22.4M |
| Income tax expense | -€621.0K | €3.2M |
| Profit for the year | -€36.9M | -€25.6M |
| — attributable to owners | -€36.9M | -€25.6M |
| Total comprehensive income | -€36.6M | -€25.7M |
| Cash flow statement | ||
| Net cash from operating activities | €7.0M | €10.4M |
| Net cash from investing activities | -€7.8M | -€5.2M |
| Purchase of PP&E (capex) | €7.8M | €5.2M |
| Purchase of intangibles | €11.0K | €13.0K |
| Net cash from financing activities | €732.0K | -€5.0M |
| Dividends paid | €0 | €0 |
| Lease liability payments | €663.0K | €728.0K |
| Balance sheet | ||
| Total assets | €97.0M | €92.7M |
| Non-current assets | €7.9M | €24.1M |
| Property, plant & equipment | €5.5M | €22.1M |
| Right-of-use assets | €1.1M | €1.0M |
| Current assets | €89.2M | €68.6M |
| Inventories | €54.3M | €38.8M |
| Trade & other receivables | €32.8M | €28.0M |
| Cash & equivalents | €89.0K | €235.0K |
| Total equity | -€31.1M | €5.5M |
| Non-current liabilities | €2.1M | €52.6M |
| Long-term borrowings | €0 | €50.0M |
| Lease liabilities (non-current) | €596.0K | €560.0K |
| Current liabilities | €126.0M | €34.6M |
| Short-term borrowings | €60.7M | €9.3M |
| Lease liabilities (current) | €460.0K | €519.0K |
| Derived metrics | ||
| Free cash flow | -€867.0K | €5.2M |
| Operating margin | -15.7% | -10.5% |
| Net margin | -15.8% | -12.6% |
| Return on equity | 118.8% | -467.8% |
| Cash conversion ratio | -0.19× | -0.41× |
| Capex coverage | 0.89× | 1.99× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€16.0M | €5.1M |
| Adjustments For Decrease Increase In Other Assets | €0 | €0 |
| Adjustments For Decrease Increase In Other Operating Receivables | -€508.0K | €1.3M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€6.8M | €17.7M |
| Adjustments For Depreciation and Amortisation Expense | €25.1M | €22.1M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | €562.0K | €177.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | €112.0K | €35.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €2.0M | €0 |
| Adjustments For Income Tax Expense | -€621.0K | €3.2M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€95.0K | -€447.0K |
| Adjustments For Increase Decrease In Other Liabilities | €1.9M | -€335.0K |
| Adjustments For Increase Decrease In Trade Account Payable | €29.8M | -€13.0M |
| Adjustments For Interest Expense | €1.1M | €894.0K |
| Adjustments For Interest Income | €0 | €0 |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €0 | €27.0K |
| Adjustments For Provisions | €8.4M | €0 |
| Basic and Diluted Earnings Loss Per Share | €-144.82 | €-100.37 |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €1.4M | -€4.3M |
| Comprehensive Income Attributable To Owners of Parent | -€36.6M | -€25.7M |
| Current Contract Liabilities | €3.1M | €466.0K |
| Current Provisions | €8.4M | €0 |
| Current Tax Assets Current | €300.0K | €300.0K |
| Deferred Tax Assets | €1.2M | €670.0K |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €27.6M | €22.3M |
| Equity and Liabilities | €97.0M | €92.7M |
| Finance Income | €378.0K | €25.0K |
| General and Administrative Expense | €40.0M | €31.5M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €120.0K | -€44.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €0 | €0 |
| Increase Decrease In Cash and Cash Equivalents | -€146.0K | €171.0K |
| Intangible Assets Other Than Goodwill | €125.0K | €363.0K |
| Interest Paid Classified As Operating Activities | €1.1M | €839.0K |
| Interest Received Classified As Investing Activities | €0 | €0 |
| Liabilities | €128.1M | €87.2M |
| Noncurrent Provisions For Employee Benefits | €1.5M | €2.1M |
| Other Comprehensive Income | €362.0K | -€131.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €482.0K | -€175.0K |
| Other Current Liabilities | €2.9M | €3.7M |
| Other Current Receivables | €1.7M | €1.1M |
| Other Expense By Nature | €551.0K | €760.0K |
| Other Noncurrent Assets | €1.0K | €1.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €0 | €0 |
| Revenue and Operating Income | €235.0M | €203.8M |
| Trade and Other Current Payables To Trade Suppliers | €50.5M | €20.7M |
Every line item above is a fact tagged in ROSIER's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.